Contact: Dr. Georges Grinstein
Chairman, AnVil Scientific Advisory Committee
(978) 934-3627
E-mail: grinstein@anvilinformatics.com

May 17, 2000

AnVil Informatics, Inc. strengthens its Scientific Advisory Committee
Appoints Dr. Nathan Goodman, Dr. Peter Schad and Dr. Gregory Tucker-Kellogg

Lowell, MA -- AnVil Informatics, Inc. has announced the appointment of Nathan Goodman, Ph.D, Peter A. Schad, Ph.D and Gregory W. Tucker-Kellogg, Ph.D to its Scientific Advisory Committee to guide AnVil’s development as a bioinformatics professional services and software company.

Dr. Nathan Goodman is an internationally recognized authority in bioinformatics. He was the founding member of the Whitehead Institute for Biomedical Research Center for Genome Research and directed the Center’s Informatics Core. Most recently, Dr. Goodman was the Director of the Bioinformatics Center at Compaq Computer Corporation. Dr. Goodman has held senior scientific positions in various large companies as well as startup and consulting businesses, such as The Jackson Laboratory, Marble Associates, Inc., Codd and Date, Inc., Kendall Square Research Corporation, Encore Computer Corporation, etc.

Dr. Nathan Goodman has also been very active in the academic field. He was an Associate Professor of Computer Science at Boston University and an Assistant Professor of Computer Science Harvard University. Dr. Goodman received his BS and MS from Massachusetts Institute of Technology and his Ph.D from Harvard University.

Dr. Peter Schad has over twenty years of experience in biotechnology. He has served as the Chief Scientific Officer for AlphaGene, Inc. since 1998. Previously, he was the Vice President for Bioinformatics and Biotechnology at the National Center for Genome Resources. Dr. Schad also served as a senior scientist for several biotechnology companies, including Bio-Rad Laboratories, PathoGenesis Corporation, Praxis Biologics, etc.

Dr. Schad is also an adjunct faculty member at New Mexico State University and The University of New Mexico Medical School. He has authored numerous scientific publications and book chapters and received multi-million dollar research grants from the Department of Energy and Department of Defense.

Dr. Gregory Tucker-Kellogg is currently a bioinformatics scientist at Millennium Predictive Medicine managing a growing bioinformatics group for diagnostic and pharmacogenomics products. He most recently served as Principal Scientist and Lab Head for the Expression Profiling Bioinformatics group at Wyeth Ayerst Research/Genetics Institute. He was responsible for gene expression bioinformatics for the entire Wyeth Ayerst Research enterprise. Dr. Tucker-Kellogg has also been an invited speaker at numerous scientific meetings.

Dr. Tucker-Kellogg received his BS from Carnegie-Mellon University, his M.Phil and Ph.D. from Yale University. Dr. Tucker-Kellogg was a Jane Coffin Childs Fellow at Harvard Medical School.

AnVil's President and Chief Executive Officer Howard Berke commented: "We are very pleased that Dr. Goodman, Dr. Schad and Dr. Tucker-Kellogg have agreed to become scientific advisors to AnVil. They bring deep knowledge and broad experience from both the information technology and pharmaceutical/ biotechnology industry to AnVil and will further accelerate AnVil’s development into a successful bioinformatics company."

Dr. Georges Grinstein, Chairman of AnVil’s Scientific Advisory Committee added: "Dr. Goodman, Dr. Schad and Dr. Tucker-Kellogg all work and live in the greater Boston area. This enables them to frequently interact with the scientists at AnVil and strategically steer AnVil’s scientific direction to serve the most relevant bioinformatics research areas."

Dr. Goodman, Dr. Schad and Dr. Tucker-Kellogg join AnVil’s existing Scientific Advisory Committee, consisting of Dr. Georges Grinstein, Dr. Kenneth Marx, Dr. Allan Green and Dr. Haim Levkowitz.

Founded in 1999, AnVil Informatics, Inc. provides data mining and visualization services to leading pharmaceutical and biotechnology companies. AnVil's combination of unique, internally developed software and commercial tools allows for the exploration of complex, large and high dimensional datasets. In addition, AnVil's technical experts harness different properties of human perception such as color, texture and shape in the process of visualizing various attributes of the complex data and their full distributions. The resulting visualizations make conclusions more evident earlier in the decision making process and can greatly enhance every step of the client's decision making process—helping them to make informed decisions faster and more accurately.

To learn more about AnVil's capabilities and offerings, visit the web site at www.anvilinformatics.com.